China Digest: Tencent backs Versa; Shanghai Cell Therapy secures $136m Series C

China Digest: Tencent backs Versa; Shanghai Cell Therapy secures $136m Series C

Artist impression of an immune system T-cell.

Legend CapitalShanghai Cell Therapy GroupTencent HoldingsVersa

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.